November 18 - 12:11
Biotech firm Benchling set for U.S. listing - report
Benchling, which supplies software and technology to the life sciences industry, has filed paperwork for a public listing in the United States according to Reuters. It was valued at $4bn after a funding round earlier this year but aims to go public in early 2022 at a "much higher" valuation. The listing will either be direct or as an initial public offering. Benchling was founded in 2012.
> Tweets